Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles

Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles

Respiratory syncytial virus (RSV) is a leading cause of severe respiratory illness in infants, young children, as well as elderly and immunocompromised patients worldwide. RSV is classified into two major subtypes, RSV-A and RSV-B, and remains the most frequently detected pathogen in infants hospita...

Full description

Saved in:
Bibliographic Details
Main Authors: Alessia Magnapera, Anna Riccio, Antonio Curcio, Caterina Tramontozzi, Lorenzo Piermatteo, Stefano D’Anna, Stefano Alcaro, Claudia Alteri, Simone La Frazia, Anna Artese, Romina Salpini, Valentina Svicher
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Viruses
Subjects:
RSV
novel drugs
mutations
drug resistance
structural dynamics
Online Access:https://www.mdpi.com/1999-4915/17/6/793
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1999-4915/17/6/793

Similar Items